Max Robotics — Global Service Robot Directory + US Certification

About

Daniel M. Morgan is a leading figure in gynecologic surgery whose research has fundamentally shaped how clinicians approach hysterectomy for benign conditions. His work centers on comparing surgical routes—robotic, laparoscopic, and vaginal—to optimize patient outcomes and minimize complications. A landmark study, cited over 70 times, demonstrated that robotic hysterectomy offers no significant advantage over other minimally invasive approaches for benign indications, a finding that has influenced surgical guidelines and practice patterns. Morgan has also been instrumental in identifying risk factors for conversion to laparotomy, with a highly cited 2016 paper showing that obesity, uterine size, and surgical history are key predictors. His research on infection prevention is equally impactful: a 2017 study, with 54 citations, provided strong evidence that adding metronidazole to cefazolin reduces surgical site infections after hysterectomy, prompting changes in antibiotic prophylaxis protocols. Beyond these contributions, Morgan has investigated hemostatic agent safety, venous thromboembolism prophylaxis, and the declining use of vaginal hysterectomy in the U.S., highlighting disparities in surgical access. His work is characterized by large, multicenter database analyses that yield actionable, evidence-based recommendations. With over 250 total citations across his most-cited papers, Morgan’s research continues to drive safer, more effective surgical care for women.